Inhibiting CD39 on macrophages significantly increases their production of tumor necrosis factor-α (TNF) and interleukin-12 (IL-12), while decreasing IL-10 secretion, thus inhibiting tumor growth (31, 32). Here, ENTPD1 is linked to neoplasm.